Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBC Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBC

The chemotherapy duo performed better than expected as a stand-in for bacillus Calmette-Gu érin (BCG), which is the gold standard for non–muscle-invasive bladder cancer but is currently in short supply.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news